A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay.
Antibodies
COVID-19
Infection
SARS-CoV-2
Serology
Journal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
02
09
2020
accepted:
14
09
2020
pubmed:
23
9
2020
medline:
15
12
2020
entrez:
22
9
2020
Statut:
ppublish
Résumé
Antibodies to SARS-CoV-2 serve as critical diagnostic markers for determining how broadly the COVID-19 pandemic has spread, confirming patient recovery, monitoring potential long-term effects of infection, and evaluating potential protection from reinfection. As new antibody tests become available, it is important to evaluate their performance and utility. The aim of this study was to compare the performance of the Abbott Panbio Two panels of specimens were utilized to challenge both antibody tests: (1) a set of 150 prepandemic negative specimens collected in 2014, and (2) a set of 122 specimens from 87 hospitalized COVID-19 patients in the US and UK that were confirmed with a positive SARS-CoV-2 RNA test result. The Architect There is good concordance between the Architect
Identifiants
pubmed: 32961429
pii: S1386-6532(20)30387-5
doi: 10.1016/j.jcv.2020.104645
pmc: PMC7493757
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104645Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.
Références
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Int J Infect Dis. 2020 Apr;93:264-267
pubmed: 32114193
Lancet Infect Dis. 2020 Sep;20(9):1051-1060
pubmed: 32539986
J Infect. 2020 Jul;81(1):147-178
pubmed: 32209385
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
Eur Respir J. 2020 Aug 27;56(2):
pubmed: 32430429
J Med Case Rep. 2017 Apr 17;11(1):111
pubmed: 28412974
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Wellcome Open Res. 2020 Jun 11;5:139
pubmed: 33748431
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Lancet Infect Dis. 2020 Sep;20(9):e245-e249
pubmed: 32687805
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Nat Commun. 2020 Sep 17;11(1):4698
pubmed: 32943630
CMAJ. 2003 May 27;168(11):1399-405
pubmed: 12771068
J Microbiol Immunol Infect. 2021 Apr;54(2):159-163
pubmed: 32265180